This image is not available for purchase in your country.

Ebola vaccine

Ebola vaccine

C025/0057

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

ROB JUDGES / OXFORD UNIVERSITY IMAGES / SCIENCE PHOTO LIBRARY ROB JUDGES / OXFORD UNIVERSITY IMAGES / SCIENCE PHOTO LIBRARY

Restrictions:

Commercial use requires clearance.

Caption

Male volunteer receiving a dose of the investigational NIAID/GSK ebola vaccine. This trial will determine if the vaccine is safe in humans and if it induces an adequate immune response. The vaccine uses a chimpanzee cold virus (chimp adenovirus type 3) to carry the genetic material for an ebola virus protein. The viruses cause ebola virus disease (EVD), a severe and often fatal disease with symptoms including fever, fatigue, muscle aches, vomiting, diarrhoea and haemorrhaging (internal bleeding). It is spread through direct contact with infected bodily fluids. There is no cure for the disease, but three quarters of patients can recover if provided with sufficient medical support. Photographed at the University of Oxford, UK.

Release details

Model release available. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}